ATE169740T1 - Stabilisierte troponin-zubereitung für immunoassays und verfahren zur deren herstellung - Google Patents

Stabilisierte troponin-zubereitung für immunoassays und verfahren zur deren herstellung

Info

Publication number
ATE169740T1
ATE169740T1 AT96401041T AT96401041T ATE169740T1 AT E169740 T1 ATE169740 T1 AT E169740T1 AT 96401041 T AT96401041 T AT 96401041T AT 96401041 T AT96401041 T AT 96401041T AT E169740 T1 ATE169740 T1 AT E169740T1
Authority
AT
Austria
Prior art keywords
immunoassays
preparation
production
stabilized troponin
troponin
Prior art date
Application number
AT96401041T
Other languages
English (en)
Inventor
Denis Robert Marie Riochet
Original Assignee
Pasteur Sanofi Diagnostics
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Sanofi Diagnostics filed Critical Pasteur Sanofi Diagnostics
Application granted granted Critical
Publication of ATE169740T1 publication Critical patent/ATE169740T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4716—Muscle proteins, e.g. myosin, actin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/96—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood or serum control standard
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4712—Muscle proteins, e.g. myosin, actin, protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/105831—Protein or peptide standard or control [e.g., hemoglobin, etc.]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/107497—Preparation composition [e.g., lysing or precipitation, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT96401041T 1995-05-16 1996-05-13 Stabilisierte troponin-zubereitung für immunoassays und verfahren zur deren herstellung ATE169740T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9505788A FR2734267B1 (fr) 1995-05-16 1995-05-16 Composition stabilisee de troponine pour immunoessais et procede de preparation d'une telle composition stabilisee

Publications (1)

Publication Number Publication Date
ATE169740T1 true ATE169740T1 (de) 1998-08-15

Family

ID=9479025

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96401041T ATE169740T1 (de) 1995-05-16 1996-05-13 Stabilisierte troponin-zubereitung für immunoassays und verfahren zur deren herstellung

Country Status (9)

Country Link
US (2) US20010006683A1 (de)
EP (1) EP0743522B1 (de)
JP (1) JP3672672B2 (de)
AT (1) ATE169740T1 (de)
CA (1) CA2176655C (de)
DE (1) DE69600512T2 (de)
DK (1) DK0743522T3 (de)
ES (1) ES2122768T3 (de)
FR (1) FR2734267B1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0938678B1 (de) * 1996-06-25 2003-09-03 OY Aboatech AB Verfahren und kit zur diagnose von troponin i
US7285418B2 (en) 1996-06-25 2007-10-23 Hytest Ltd. Method and kit for the diagnosis of troponin I
DE19647927A1 (de) * 1996-11-20 1998-05-28 Bayer Ag Verfahren zur Herstellung einer stabilen Troponin I Präparation und dessen Verwendung als Kalibrator in Immunoassays
US5834210A (en) * 1997-05-23 1998-11-10 Spectral Diagnostics, Inc. Stable troponin subunits and complexes
US6248869B1 (en) 1997-05-29 2001-06-19 Medical Analysis Systems, Inc. Troponin I forms and use of the same
EP0983299A1 (de) * 1997-05-29 2000-03-08 Medical Analysis Systems, Inc. Kovalent-gekoppelte troponinkomplexen
EP1000140A1 (de) * 1997-06-13 2000-05-17 Medical Analysis Systems, Inc. (MAS) Stabilisierte herz-marker-zusammensetzungen
WO2006116005A2 (en) * 2005-04-28 2006-11-02 Abbott Laboratories Stabilization of cardiac troponin
US10634681B2 (en) 2011-02-25 2020-04-28 Lsi Medience Corporation Method for measuring cardiac troponin
JP5759211B2 (ja) * 2011-03-11 2015-08-05 三洋化成工業株式会社 凍結乾燥方法
CN113125745B (zh) * 2019-12-31 2022-10-28 瑞博奥(广州)生物科技股份有限公司 一种心脏功能检测试剂盒

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2027434C (en) * 1990-10-12 1999-01-05 George Jackowski Diagnostic kit for diagnosing and distinguishing chest pain in early onset thereof
DE4243648A1 (de) * 1992-12-23 1994-07-07 Boehringer Mannheim Gmbh Verfahren zur Bestimmung von Herzmuskelnekrosen mittels Antikörper gegen das N-terminale Troponin I-Peptid
FR2701954B1 (fr) * 1993-02-23 1995-07-07 Pasteur Sanofi Diagnostics Composition stabilisée de troponine pour immunoessais et procédé de stabilisation de troponine pour immunoessais.
JPH09503050A (ja) * 1993-05-17 1997-03-25 フォートロン バイオサイエンス インク． 心臓トロポニン▲ｉ▼のアッセイ
DE4420742A1 (de) * 1993-10-20 1995-04-27 Boehringer Mannheim Gmbh Synthetischer Standard für Immunoassays

Also Published As

Publication number Publication date
DE69600512D1 (de) 1998-09-17
US20010006683A1 (en) 2001-07-05
ES2122768T3 (es) 1998-12-16
CA2176655A1 (en) 1996-11-17
EP0743522A1 (de) 1996-11-20
JP3672672B2 (ja) 2005-07-20
JPH0921804A (ja) 1997-01-21
DK0743522T3 (da) 1999-05-10
CA2176655C (en) 2002-01-29
EP0743522B1 (de) 1998-08-12
DE69600512T2 (de) 1999-04-15
US20040033529A1 (en) 2004-02-19
FR2734267A1 (fr) 1996-11-22
FR2734267B1 (fr) 1997-08-01

Similar Documents

Publication Publication Date Title
AT384805B (de) Verfahren zur herstellung von neuen 1,2-diaminocyclobuten-3,4-dionen und deren salzen
ATE169740T1 (de) Stabilisierte troponin-zubereitung für immunoassays und verfahren zur deren herstellung
AT383606B (de) Verfahren zur herstellung von neuen transparenten copolyamiden mischungen daraus, und deren verwendung zur herstellung von formkoerpern
ATA122485A (de) Verfahren zur herstellung von neuen 1,4-dihydro-4-oxonaphthyridin-derivaten und deren salzen
DE3867684D1 (de) Kupferoxid-supraleiter mit gemischter wertigkeit und verfahren zu seiner herstellung.
DE69526863D1 (de) Neue 1,2-dioxetane mit haloalkoxy-gruppen, verfahren zur herstellung und verwendung
ATE188976T1 (de) Kontinuierliches verfahren zur herstellung von resorbierbaren polyestern und deren verwendung
DE3678071D1 (de) Verfahren zur herstellung von polyvinylidenfluoridpfropfcopolymeren und membranen aus polyvinylidenfluoridpolymeren mit diesem verfahren erhalten.
ATE148110T1 (de) Verfahren zur herstellung von metallkomplexen der n-beta-hydroxy-alkyl-tri-n-carboxyalkyl-1,4,7,1 - tetraazacyclododecan- und n-beta-hydroxyalkyl-tri-n-carboxyalkyl-1,4,8,11 tetraazacyclotetradecan- derivate
ATA902383A (de) Verfahren zur herstellung neuer 2,3,4-trinor-1,5 -inter-m-phenylen-prostacyclin-i2-analoga und von deren salzen
AT388738B (de) Verfahren zur herstellung von wasserverduennbaren lackbindemitteln und deren verwendung
ATE80388T1 (de) Verfahren zur herstellung von 5-gliedrigen, stickstoffhaltigen heteroaromaten.
DE3785537D1 (de) Mikroorganismus und verfahren zur herstellung von oxydationsverbindungen mit diesem mikroorganismus.
DE3670093D1 (de) Mischungen aus polyphenylenether und polyamid und deren verwendung zur herstellung thermoplastischer formmassen.
DE68903570T2 (de) Verfahren zur herstellung von hydroxyalkylierungsmitteln, die erhaltenen mittel und deren verwendung.
DE3688854D1 (de) Verfahren zur herstellung von polythiobisphenolen und verfahren zur herstellung von mercaptophenolen durch hydrogenolyse der polythiobisphenole.
AT388382B (de) Verfahren zur herstellung von wasserverduennbaren lackbindemitteln und deren verwendung
ATA277081A (de) Verfahren zur herstellung neuer 6-hydrazono-pyrido(2,1-b)chinazolin-11-on-deriv te, von deren salzen sowie von deren stereomeren
ATA91186A (de) Verfahren zur herstellung von n-(1(s)|thoxycarbonyl-3-phenyl-propyl)-(s)-alanyl-(s)prolin und von dessen saeureadditionssalzen
ATE127127T1 (de) Verfahren zur herstellung einer intramolekularen disulphid-brücke in polypeptiden.
DE68908843T2 (de) Verfahren zur Herstellung von 4,6-Dimethyl-7-hydroxynonan-3-on.
ATE95839T1 (de) Antibiotika ''mureidomycine a,b,c und d'' genannt, deren verfahren zur herstellung und deren verwendung.
DE3866773D1 (de) Verfahren zur herstellung von acetylenepoxiden und deren verwendung.
AT384806B (de) Verfahren zur herstellung von neuen 4-aryl-2-methyl-1,2,3,4-tetrahydro-isochinolinderivaten und deren salzen
ATE99683T1 (de) 2,5,6,7-tetranor-4,8-inter-m-phenylen 2-pgiderivate, verfahren zur herstellung und deren verwendung.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEFA Change of the company name
EEFA Change of the company name